Product Information
ERYTHROMYCIN-BENZOYL GEL is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.5991 per GM under NDC 64980032801. Its NADAC has been published 512 times since Dec 14, 2016.
FDA first approved this application on Sep 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50; 30 mg/g; mg/g
Manufacturer
Rising Pharma Holdings Inc.NDC
64980032801
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA065385FDA Approved
9/18/2015
TE Code
AB
On Market Since
10/18/2016
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN-BENZOYL GEL has been published 512 times since Dec 14, 2016, and over the history we have for it it has declined 73.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5991 per GM |
|---|---|
| All-time high | $6.0413 (Jul 12, 2017) |
| All-time low | $1.3020 (May 22, 2024) |
| 52-week high | $2.0094 |
| 52-week low | $1.4808 |
| Median price | $2.2757 |
| Average price | $2.7667 |
| Largest weekly change | +77.0% (Jun 23, 2021) |
| Weeks tracked | 512 |
| Tracking since | Dec 14, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin and Benzoyl Peroxide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN-BENZOYL GEL?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN-BENZOYL GEL, manufactured by Rising Pharma Holdings Inc., is $1.5991 per GM (NDC 64980032801), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN-BENZOYL GEL changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN-BENZOYL GEL has declined 73.2%. It has been tracked across 512 weekly CMS publications since Dec 14, 2016.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN-BENZOYL GEL?
Since Dec 14, 2016, the NADAC for ERYTHROMYCIN-BENZOYL GEL has ranged from a low of $1.3020 (May 22, 2024) to a high of $6.0413 (Jul 12, 2017), with a median of $2.2757 per GM.
Are there cheaper alternatives to ERYTHROMYCIN-BENZOYL GEL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN-BENZOYL GEL, is $1.0332 per GM — about 35% below ERYTHROMYCIN-BENZOYL GEL.
Who manufactures ERYTHROMYCIN-BENZOYL GEL?
ERYTHROMYCIN-BENZOYL GEL (NDC 64980032801) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.